Mucosal immunology down under: Special interest group in mucosal immunology workshop, Australasian Society for Immunology, Sydney, Australia, 2 December 2007

Immunology and Cell Biology

Volumn 86, Issue 7, 2008, Pages 557-561

  Cripps, Allan W ^a   Sutton, Philip ^b   Beagley, Ken ^c   Robertson, Sarah ^d   Dunkley, Margaret ^e  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Chlamydia; Common mucosal immune system; Gastrointestinal immunity; Haemophilus influenzae; Helicobacter pylori M cell targeting; Middle ear; Otitis media; Reproductive immunity; Respiratory immunology; Vaccine

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; PROTEIN MOMP; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VACCINE;

AUSTRALIA; BIOINFORMATICS; CD8+ T LYMPHOCYTE; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; GASTROINTESTINAL TRACT; HERPES SIMPLEX VIRUS; HUMAN; IMMUNIZATION; IN VITRO STUDY; MIDDLE EAR; MUCOSAL IMMUNITY; NONHUMAN; REPRODUCTION; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; VACCINATION;

ANIMALS; AUSTRALIA; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY, MUCOSAL; RESPIRATORY SYSTEM; VACCINES;

CHLAMYDIA; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI;

EID: 53249115190     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2008.53     Document Type: Conference Paper

References (23)

1. Baker CJ, Beagley KW, Hafner LM, Timms P. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB. Vaccine 2008; 26: 1285-1296.
2. Berry LJ, Hickey DK, Skelding KA, Bao S, Rendina AM, Hansbro PM et al. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infect Immun 2004; 72: 1019-1028.
3. Skelding KA, Hickey DK, Horvat JC, Bao S, Roberts KG, Finnie JM et al. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection. Vaccine 2006; 24: 355-366.
4. Girling JE, Hedger MP. Toll-like receptors in the gonads and reproductive tract: emerging roles in reproductive physiology and pathology. Immunol Cell Biol 2007; 85: 481-489.
5. Robertson SA. Seminal plasma and male factor signalling in the female reproductive tract. Cell Tissue Res 2005; 322: 43-52.
6. Sharkey DJ, Macpherson AM, Tremellen KP, Robertson SA. Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. Mol Hum Reprod 2007; 13: 491-501.
7. Brandtzaeg P, Kiyono H, Pabst R, Russell MW. Terminology: nomenclature of mucosal-associated lymphoid tissue. Mucosal Immunol 2008; 1: 31-37.
8. Blum KS, Pabst R. Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? Immun Lett 2007; 108: 45-51.
9. Luhrmann A, Grote K, Stephan M, Tschernig T, Pabst R. Local pulmonary immune stimulation by the Toll-like receptor 2 and 6 ligand MALP-2 in rats is age dependent. Immunol Lett 2007; 108: 167-173.
10. von Garnier C, Wiikstrom ME, Zosky G, Turner DJ, Sly PD, Smith M et al. Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa. J Immunol 2007; 179: 5748-5759.
11. Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser J. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proc Natl Acad Sci USA 2007; 104: 15051-15056.
12. Kaparakis M, Philpott DJ, Ferrero RL. Mammalian NLR proteins; discriminating foe from friend. Immunol Cell Biol 2007; 85: 495-502.
13. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5: 1166-1174.
14. McGuckin MA, Every AL, Skene CD, Linden SK, Chionh YT, Swierczak A et al. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology 2007; 133: 1210-1218.
15. Bourges D, Zhan Y, Brady JL, Braley H, Caminschi I, Prato S et al. Targeting the gut vascular endothelium induces gut effector CD8T cell responses via cross-presentation by dendritic cells. J Immunol 2007; 179: 5678-5685.
16. Kurono Y, Mogi G. Mucosal immunity of the middle ear. In: Kiyono J, Ogra PL, McGhee J (eds). Mucosal Vaccines. Academic Press: California, USA, 1996, pp 451-458.
17. Faden H, Stanievich J, Brodsky L, Bernstein J, Ogra PL. Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J 1990; 9: 623-626.
18. Kyd JM, Cripps AW, Novotny AL, Bakaletz LO. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx. Infect Immun 2003; 71: 4691-4699.
19. Cripps AW, Otczyk DC, Kyd JM. Bacterial otitis media: a vaccine preventable disease? Vaccine 2005; 23: 2304-2310.
20. Cripps AW, Otczyk DC. Prospects for a vaccine against otitis media. Expert Rev Vaccines 2006; 5: 517-534.
21. Aldwell FE, Tucker IG, de Lisle GW, Buddle BM. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice. Infect Immun 2003; 71: 101-108.
22. Foxwell AR, Cripps AW, Kyd JM. Optimization of oral immunization through receptor-mediated targeting of M cells. Hum Vaccin 2007; 3: 220-223.
23. Gupta PN, Mahor S, Rawat A, Khatri K, Goyal A, Vyas SP. Lectin anchored stabilized biodegradable nanoparticles for oral immunization: 1. Development and in vitro evaluation. Inter J Pharm 2006; 318: 163-173.